ANXA9 and inflammatory bowel disease: Patients with UC are at increased risk for CRC (77, 78), and genes such as Annexin A9 (Anxa9) and Atp2a1 have been identified as poor prognostic markers in CRC and potential mediators of IBD progression (79, 80).